This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Comparative Effectiveness (continued)
- How should it be linked to coverage decisions by payers?
- Should not serve the cost containment concerns of payers
- Might be most useful in informing treatment options and assigning appropriate reimbursement premiums
- How should this information be communicated?
- Share widely with all stakeholders, particularly providers and patients
- Consider the dangers of incomplete understanding of results, particularly when communicated in an overly simplistic manner
- Acknowledge that CE information can be incomplete, misleading, or misinterpreted
- How should stakeholders be involved?
- Participate in framing the methods that will be used and prioritizing the key therapeutic areas
- Promote transparency about the processes, findings, limitations, and appropriate uses of the information
Previous Slide Contents Next Slide 
5600 Fishers Lane Rockville, MD 20857